A R Lorimer

12.6k total citations · 2 hit papers
112 papers, 9.5k citations indexed

About

A R Lorimer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A R Lorimer has authored 112 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A R Lorimer's work include Blood Pressure and Hypertension Studies (20 papers), Lipoproteins and Cardiovascular Health (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). A R Lorimer is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Lipoproteins and Cardiovascular Health (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). A R Lorimer collaborates with scholars based in United Kingdom, United States and Sweden. A R Lorimer's co-authors include Christopher J. Packard, James Shepherd, Peter W. Macfarlane, James H. McKillop, Stuart M. Cobbe, Ian Ford, Christopher Isles, J. Shepherd, T. D. V. Lawrie and C.J. Packard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

A R Lorimer

110 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 5.8k citations Stuart M. Cobbe, A R Lorimer et al. profile →
Pravastatin and the Development of Diabetes Mellitus

2001 667 citations Stuart M. Cobbe, A R Lorimer et al. profile →

Peers

Countries citing papers authored by A R Lorimer

Since Specialization

Citations

This map shows the geographic impact of A R Lorimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A R Lorimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A R Lorimer more than expected).

Fields of papers citing papers by A R Lorimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A R Lorimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A R Lorimer. The network helps show where A R Lorimer may publish in the future.

Co-authorship network of co-authors of A R Lorimer

This figure shows the co-authorship network connecting the top 25 collaborators of A R Lorimer. A scholar is included among the top collaborators of A R Lorimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A R Lorimer. A R Lorimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired heart rate variability and increased ventricular ectopic activity in patients with left ventricular hypertrophy 1994 ·Journal of Electrocardiology ·(unknown), David Wallbridge, Stuart D. Pringle, (unknown), (unknown), Peter W. Macfarlane, A R Lorimer, Stuart M. Cobbe	3
2	Probucol reduces plasma lipid peroxides in man 1992 ·Atherosclerosis ·(unknown), (unknown), (unknown), Graeme W. Tait, (unknown), C.J. Packard, (unknown), A R Lorimer	13
3	Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy 1992 ·The American Journal of Cardiology ·Stuart D. Pringle, Francis G. Dunn, Peter W. Macfarlane, James H. McKillop, A R Lorimer, Stuart M. Cobbe	41
4	11. Efficacy and tolerability of an atriopeptidase inhibitor, candoxatril in essential hypertension 1991 ·Journal of Hypertension ·(unknown), Gordon T. Mclnnes, A R Lorimer, H A Carmichael, J. J. Brown, John Connell, D. L. Davies	1
5	The pathophysiological significance of ventricular arrhythmias in hypertensive left ventricular hypertrophy 1990 ·Journal of the American College of Cardiology ·Stuart D. Pringle, (unknown), James H. McKillop, A R Lorimer, Francis G. Dunn, Stuart M. Cobbe	1
6	The Safety of Felodipine 1990 ·Journal of Cardiovascular Pharmacology ·A R Lorimer, Steven Pringle	4
7	Antianginal Effect of Felodipine 1990 ·Journal of Cardiovascular Pharmacology ·A R Lorimer, P. W. Macfarlane, Steven Pringle, (unknown), (unknown), T. D. V. Lawrie	1
8	Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension 1989 ·Journal of the American College of Cardiology ·Stuart D. Pringle, Peter W. Macfarlane, James H. McKillop, A R Lorimer, Francis G. Dunn	52
9	Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia 1989 ·Metabolism ·J.J. Series, Muriel Caslake, (unknown), A. Cruickshank, Thomas Demant, A R Lorimer, C.J. Packard, J. Shepherd	15
10	Comparison of Amlodipine and Verapamil in the Treatment of Mild to Moderate Hypertension 1988 ·Journal of Cardiovascular Pharmacology ·A R Lorimer, (unknown), Paul R. Walker, H. M. Tyler	14
11	The effect of a long‐acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis 1988 ·Alimentary Pharmacology & Therapeutics ·Steven Pringle, Ruth F. McKee, O. James Garden, A R Lorimer, D C Carter	39
12	Severity of Coronary Artery Disease and Basal Fibrinolysis 1987 ·Pathophysiology of Haemostasis and Thrombosis ·Michael Small, (unknown), (unknown), I. Hutton, A R Lorimer, C.D. Forbes	14
13	Serum Oestradiol and Ischaemic Heart Disease - Relationship with Myocardial Infarction but not Coronary Atheroma or Haemostasis 1985 ·QJM ·Michael Small, G.D.O. Lowe, G. H. Beastall, (unknown), (unknown), I. Hutton, A R Lorimer, C.D. Forbes	28
14	Myocardial Infarction in Pregnancy 1985 ·Scottish Medical Journal ·S.J. Hutchison, Richard J. Holden, A R Lorimer	7
15	Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. 1984 ·Gut ·Peter R. Mills, A P Rae, (unknown), R I Russell, A R Lorimer, (unknown)	94
16	“Third drug” trial 1984 ·BMJ ·Dorothea McAreavey, A R Lorimer, James Reid, J. I. S. Robertson, (unknown), R. J. Weir, L E Ramsay, (unknown), Andrew McLaren	1
17	Relation between extent of coronary artery disease and blood viscosity. 1980 ·BMJ ·Gordon Lowe, M. M. Drummond, A R Lorimer, I. Hutton, C.D. Forbes, C. R. M. Prentice, J.C. Barbenel	219
18	Progress in Cardiology 1975 ·BMJ ·A R Lorimer	1
19	Growing Points in Cardiology 1972 ·BMJ ·A R Lorimer	1
20	Blood pressure in a scottish island community 1969 ·BMJ ·V M Hawthorne, C. Gillis, A R Lorimer, (unknown), Thomas Walker	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact